Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Esbriet: ERS RECAP Extension Safety Data Strong
-
Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); Breakthrough P2 Results Support High T-DM1 Potential
-
Canaccord Genuity Maintains a 'Speculative Buy' on Delcath Systems (DCTH); Updated Phase III Efficacy Data Positive
-
Canaccord Genuity Reiterates a 'Buy' on Green Mountain Coffee Roasters (GMCR); Q4 Preview: The End of Summer But Not This Growth Story
-
Canaccord Genuity Reiterates a 'Buy' on Finish Line (FINL); Digital Driving Growth
-
Canaccord Genuity Reiterates a 'Buy' on Apple (AAPL); Checks Indicate Continued Momentum
-
Canaccord Genuity Reiterates a 'Buy' on Spreadtrum Communications (SPRD); Raising Estimates
-
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); HIV-OTC Timeline May Improve
-
Canaccord Genuity Maintains a 'Hold' on Nike (NKE); Top Line Accelerates, and So Does Spending
-
Canaccord Genuity Maintains a 'Buy' on KIT Digital (KITD); Recent IPO Filings Bring Additional Focus to the Positive OTT Macro
-
Canaccord Genuity Reiterates a 'Buy' on Descartes (DSGX); Analyst Day Highlights Product Momentum - Hints at Growth Upside
-
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Sues Amphastar for Enox Infringement as Copaxone Suit Hearing Ends
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); Panther Trial Data Q1/12: NAC/aza/pred No Threat to Esbriet
-
Canaccord Genuity Reiterates a 'Buy' on Approach Resources (AREX); UT Lease Sale Supports Thesis on Upside Potential
-
Canaccord Genuity Maintains a 'Hold' on Intuit (INTU); We'd Like Faster Growth for the Price
-
Canaccord Genuity Reiterates a 'Buy' on salesforce.com (CRM); Acquires Assistly to Bolster Service Cloud for SMB
-
Canaccord Genuity Assumes Coverage on Westport Innovations (WPRT) at Hold; Feeding a Frenzy for Alt Fuel
-
Canaccord Genuity Maintains a 'Hold' on Xilinx (XLNX); Inventory Correction to Persist Into December Quarter
-
Canaccord Genuity Maintains a 'Hold' on NuVasive (NUVA); Infringes Three Medtronic (MDT) Patents
-
Canaccord Genuity Maintains a 'Buy' on Oracle (ORCL); Solid Quarter Reflects Economic Reality of Slow, but Not Plummeting, Macro Enviornment
-
Canaccord Genuity Maintains a 'Buy' on Comstock Resources (CRK); Liquids Transition Still in Early Innings; Eagle Ford to Drive Value
-
TranS1 (TSON) Announces Common Stock Offering
-
Notable Analyst Rating Changes 09/20: (MGM) (PHM) (ARMH) Upgraded; (MCP) (HLS) (LOGI) Downgraded
-
Canaccord Genuity Morning Coffee on Tyco Int'l (TYC): Back on the Market
-
Canaccord Genuity on Technology/Hardware: Semiconductor Devices and Related Technologies
-
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); HCV Update
-
Canaccord Genuity Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Dark Horse Amphastar Enox Approved: Other Shoe Drops
-
Canaccord Genuity Reiterates a 'Buy' on Horsehead Holding (ZINC); New Plant to be Located in North Carolina
-
Canaccord Genuity Reiterates a 'Buy' on Finish Line (FINL); Q2 Preview: Looking for Comp and Margin Upside
-
Canaccord Genuity Maintains a 'Hold' on Nike (NKE); Q1 Preview: Expecting Strong Top Line, but Margin Pressures Persist
-
UPDATE - Canaccord Genuity Initiates Coverage on Carbonite (CARB) with a Buy; Cheap and Simple Peace of Mind
-
Canaccord Genuity Starts Carbonite (CARB) at Buy
-
Canaccord Genuity Reiterates a 'Buy' on China Kanghui Holdings (KH); Meeting with Management
-
Canaccord Genuity Reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); Closer Look at Price: RP103 Price, Orphan Pricing Model
-
Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); New Data Supports 558 Promise
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); ERS'11 Abstracts: Stable or Better 2.5+ Year Esbriet Safety
-
Canaccord Genuity Reiterates a 'Buy' on Weatherford (WFT); Q3 Update
-
Canaccord Genuity Maintains a 'Buy' on ENSCO International (ESV); Downtime Lowers Estimates
-
Canaccord Genuity reiterates a 'Buy' on Continental Resources (CLR); Raising PT on Higher H2/11 Oil Production Outlook
-
Canaccord Genuity Starts Anacor Pharmaceuticals (ANAC) at Buy
-
Mascoma Corp. Files $100M IPO
-
Canaccord Genuity Reiterates a 'Buy' on Trius Therapeutics (TSRX); First Tedizolid Phase III Trial Enrollment Completed
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Crystal Clear?
-
Canaccord Genuity Maintains a 'Hold' on Research In Motion (RIMM); Weak Q2/F2012 Results, Disappointing GM Guide Leads to Lower Estimates
-
Canaccord Genuity on Constant Contact (CTCT); High Noon in Waltham: It's Time For CTCT To Step Up
-
Canaccord Genuity Maintains a 'Buy' on Goodrich Petroleum (GDP) After Meeting with Management; Disproportionate Equity Value Upside
-
Canaccord Genuity Maintains a 'Hold' on Transocean (RIG); Fleet Status Update
-
Canaccord Genuity Assumes Coverage on Voyager Oil & Gas (VOG) at Buy; High-Beta Play for Second-Half Bakken Bounce Back
-
Canaccord Genuity Assumes Coverage on Swift Energy (SFY) at Buy; Undervalued Asset Base with Significant Resource Potential
-
Canaccord Genuity Assumes Coverage on REX Energy (REXX) at Buy; Meaningful Catalysts to Drive Second-Half Alpha Generation
